The Latest Breaking News from US Federal Reserve

Inflation is at a 40-year high

While NZDUSD continued its bearishness last week, it showed a strong move up on Wednesday to produce a Thursday high. However, it sold off very quickly as it continued its drop during Thursday's London and New York sessions.

Investors' worries over the Fed’s aggressive stance to fight the multi-decade high inflation and intensifying geopolitical tensions have recently pushed benchmark indexes into correction territory. Therefore, many quality stocks are trading at attractive valuations now. Since value companies often do well in an inflationary environment, it could be prudent to…

Last week, the Federal Reserve announced that it’s raising interest rates by half a percentage point, bumping the federal funds rate to a target range of 0.75 to 1.00 percent. The move follows an increase of 0.25 percent in March, as the Fed continues reducing liquidity to the financial markets…

Amid rising worries over surging inflation, the Federal Reserve’s hawkish tilt, geopolitical uncertainties, and supply chain crisis, consumer defensive stocks have outperformed the broader market so far. However, not all stocks in this sector are well-positioned to dodge the market’s volatility. For example, lately, Clorox Company (CLX) and Estée Lauder…

Twenty-two Democratic members of Congress are urging the Federal Reserve Bank of Dallas to appoint the first Latino regional president to fill the top position that’s been vacant since October.

Shares of crypto-related stocks, including Bitfarms Ltd (NASDAQ: BITF), Coinbase Global Inc (NASDAQ: COIN) and Riot Blockchain Inc (NASDAQ:

Sterling’s recent tumble is just the latest in a saga of painful episodes for successive UK governments. During the post-war era of “fixed but adjustable” exchange rates, British politicians were regularly faced with the terrifying risk of a currency devaluation. Poor underlying competitiveness left successive administrations facing severe trade deficits.…

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 percent during the week.

The stock market has been under pressure of late for various macroeconomic and geopolitical reasons. Investors are primarily worried now that the Fed’s aggressive monetary policy tightening to tame surging inflation could tip the economy into recession. We think investors who believe the market has still to hit bottom even…

Value stocks continue to be the lone bright spot in this gloomy market. How to use the StockNews screener to uncover some hidden diamonds in the rough.